Data from the WHO's sentinel surveillance system spread across 84 countries show that the percentage of people testing positive for the virus has been rising over the past few weeks. Overall, more than 10 percent tested positive. The ratio fluctuates by region. In Europe, the positive rate is more than 20%. The Americas, Europe and the Western Pacific are all seeing new waves of infections.

Recently, the positive rate of COVID-19 has been increasing globally, with increases in the Eastern Mediterranean, Europe and the Americas, and decreases in other regions. At present, JN.1, KP.2 and KP.3 are the main circulating strains in the world, and the variant strain LB.1 is listed as a variant strain under surveillance (VUM) by WHO.

According to multiple data, the total number of hospital admissions for COVID-19 cases reached 2,088 in the week ending Nov. 25, and more than 19,400 new hospitalizations of mycoplasma pneumoniae, meanwhile the RSV also entered the peak of infection.

Academician Zhong Nanshan said at the Biomedicine and Health sub-forum of the 2023 Greater Bay Area Science Forum that the forecast based on the seirs model shows that the peak of the second wave of the SARS-CoV-2 epidemic in 2023 will occur at the end of June, about 65 million per week.

On the afternoon of December 21, Xiamen Wiz Biotech Co., Ltd. and Xiamen Zhuqiang Large Pharmacy Co., Ltd. had an in-depth discussion on how to meet citizens' demand for novel coronavirus antigen test kits, reached and established a strategic partnership, to assist Xiamen in epidemic prevention and control.

On December 21, Xiamen Wiz Biotech Co., Ltd and Xiamen Luyan Pharmacy Co., Ltd signed a strategic cooperation on COVID-19 antigen test kit. Su Jinkun (Mr.), General manager of Xiamen Luyan Pharmacy, Lin Lin (Ms.), Deputy general manager of Retail Division of Luyan Group, and Wang Xiaozhen (Ms.), general manager of Wiz Biotech, Sales Director Peng Que'en (Mr.) attended the ceremony.